The Venture Codex Logo

The Venture Codex

Boehringer Ingelheim

Binger Strasse 173, Ingelheim am Rhein, Rheinland-Pfalz, 55216, Germany

Overview

Research-driven pharmaceutical company improving health and quality of life

Founded

1885

Deals · 12mo

6

Links

WebsiteLinkedInX (Twitter)

Stage focus

Seed
Series A
Series B

Geographic focus

Belgium
France
Germany
Switzerland
...

Sector focus

Biotechnology
Health Care
Medical
Pharmaceutical

Investment portfolio

76rounds
NAMEDATESIZE
Cloverleaf Bio
Sep 2026Participated
$33 MSeed
smartbax
Jul 2026Participated
$2 MSeries A
Tacalyx
Apr 2026Participated
$13 MSeed
Click Therapeutics
Apr 2026Led
$50 MSeries D
TECregen
Jan 2026Led
$13 MSeed
smartbax
Oct 2025Participated
$5 MSeries A
Nuevocor
May 2025Participated
$45 MSeries B
Brainomix
Mar 2025Led
$19 MSeries C
Refoxy Pharmaceuticals
Dec 2024Led
$11 MSeed
Aignostics
Oct 2024Participated
$34 MSeries B
HepaRegeniX
Jul 2024Participated
$16 MSeries C
Tacalyx
Jun 2024Participated
$15 MSeed
Cloverleaf Bio
Sep 2026Participated
$33 MSeed
smartbax
Jul 2026Participated
$2 MSeries A
Tacalyx
Apr 2026Participated
$13 MSeed
Click Therapeutics
Apr 2026Led
$50 MSeries D
TECregen
Jan 2026Led
$13 MSeed
smartbax
Oct 2025Participated
$5 MSeries A
Nuevocor
May 2025Participated
$45 MSeries B
Brainomix
Mar 2025Led
$19 MSeries C
Refoxy Pharmaceuticals
Dec 2024Led
$11 MSeed
Aignostics
Oct 2024Participated
$34 MSeries B
HepaRegeniX
Jul 2024Participated
$16 MSeries C
Tacalyx
Jun 2024Participated
$15 MSeed
76
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Boehringer Ingelheim: 76 funding rounds are recorded in the selected participation categories.All available history.
Boehringer Ingelheim: 76 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed114
Series A1414
Series B415
Series C+45
Other Equity23

Monthly Deal Activity

Boehringer Ingelheim: 76 deals are recorded across 194 months.All available history.
Boehringer Ingelheim: 76 deals are recorded across 194 months. All available history
MonthDeals
Sep '101
Oct '100
Nov '100
Dec '100
Jan '110
Feb '110
Mar '110
Apr '110
May '110
Jun '110
Jul '110
Aug '110
Sep '110
Oct '110
Nov '110
Dec '110
Jan '120
Feb '120
Mar '121
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '120
Oct '120
Nov '120
Dec '121
Jan '130
Feb '130
Mar '130
Apr '130
May '131
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '131
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '140
Nov '141
Dec '140
Jan '150
Feb '150
Mar '151
Apr '150
May '150
Jun '151
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '161
Apr '161
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '161
Nov '161
Dec '161
Jan '170
Feb '170
Mar '170
Apr '170
May '172
Jun '170
Jul '170
Aug '170
Sep '171
Oct '170
Nov '170
Dec '172
Jan '180
Feb '180
Mar '180
Apr '181
May '181
Jun '181
Jul '180
Aug '180
Sep '180
Oct '180
Nov '182
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '191
Jun '191
Jul '190
Aug '190
Sep '192
Oct '191
Nov '190
Dec '191
Jan '202
Feb '200
Mar '200
Apr '202
May '201
Jun '202
Jul '201
Aug '202
Sep '201
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '212
Apr '211
May '210
Jun '211
Jul '212
Aug '210
Sep '210
Oct '213
Nov '211
Dec '212
Jan '220
Feb '221
Mar '221
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '221
Oct '220
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '230
May '232
Jun '230
Jul '230
Aug '231
Sep '230
Oct '231
Nov '231
Dec '230
Jan '240
Feb '241
Mar '241
Apr '240
May '240
Jun '241
Jul '241
Aug '240
Sep '240
Oct '241
Nov '240
Dec '241
Jan '250
Feb '250
Mar '251
Apr '250
May '251
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '261
Feb '260
Mar '260
Apr '262
May '260
Jun '260
Jul '261
Aug '260
Sep '261
Oct '260

Sector Breakdown

Boehringer Ingelheim: Health & Life Sciences is the largest displayed sector by deal count (75 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Boehringer Ingelheim: Health & Life Sciences is the largest displayed sector by deal count (75 deals). All available history
SectorDeals
Health & Life Sciences75
AI & Machine Learning5
Space & Frontier Tech4
Manufacturing3
Consumer & Lifestyle2
Enterprise Software1
Professional Services1

Deal Size Distribution

Boehringer Ingelheim: 76 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Boehringer Ingelheim: 76 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M8
$5M-$10M9
$10M-$25M32
$25M-$50M19
$50M-$100M7
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Boehringer Ingelheim: Europe has the largest recorded deal count among the displayed regions (53 deals).All available history.

Top 6 of 6 regions; European countries are grouped as Europe.

Boehringer Ingelheim: Europe has the largest recorded deal count among the displayed regions (53 deals). All available history
RegionDeals
Europe53
United States18
Singapore2
China1
Kenya1
Canada1
Boehringer Ingelheim: 20 co-investors are shown, with High-Tech Grunderfonds sharing 18 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Boehringer Ingelheim: 20 co-investors are shown, with High-Tech Grunderfonds sharing 18 recorded deals. All available history
Co-investorShared deals
High-Tech Grunderfonds18
Kurma Partners9
BioMedPartners7
EQT Life Sciences (LSP)7
Idinvest Partners6
Novo Holdings5
Vesalius Biocapital5
Creathor Venture4
Gimv4
Wellington Partners4
Advent France Biotechnology3
Andera Partners3
Bpifrance3
Carma Fund3
coparion3
Fund+3
Korea Investment Partners3
Mitsui & Co. Global Investment3
Novartis3
Parkwalk Advisors3

Investment Strategy

Boehringer Ingelheim: Led accounts for 46% and participating for 54% of round participation.All available history.
Boehringer Ingelheim: Led accounts for 46% and participating for 54% of round participation. All available history
CategoryDeals (count)Share (%)
Led3546%
Participating4154%
Boehringer Ingelheim: Single-lead accounts for 31% and co-led for 69% of lead dynamics.All available history.
Boehringer Ingelheim: Single-lead accounts for 31% and co-led for 69% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1131%
Co-led2469%

Team

Arun Thachi

Director, IT Omnichannel Ecosystem Evolution

Christian Eckermann

SVP, Head of Biopharma Austria

Clive Wood

Senior Vice President

Jan Cassen Kraus

Head of Supply Chain Management

Klaus-Peter Kammerer

Global Clinical Program Leader

Matthias Samwer
Melanie Ruppel

Head of Global Submission Services Ingelheim

Philipp Mueller
Rainer Kirch

Head of Dept. Logistics, Foreign Trade and Mobility

Victoria Gamerman

Global Head of Data Governance and Insights